Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Operating Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Operating Margin for 9 consecutive years, with 64859.4% as the latest value for Q4 2025.

  • Quarterly Operating Margin fell 200160.0% to 64859.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 102380.23% through Dec 2025, down 5016332.0% year-over-year, with the annual reading at 102380.23% for FY2025, 5016332.0% down from the prior year.
  • Operating Margin for Q4 2025 was 64859.4% at Creative Medical Technology Holdings, down from 55349.27% in the prior quarter.
  • The five-year high for Operating Margin was 1855.31% in Q3 2022, with the low at 64859.4% in Q4 2025.
  • Average Operating Margin over 5 years is 28928.09%, with a median of 23018.04% recorded in 2024.
  • Peak annual rise in Operating Margin hit 647905bps in 2022, while the deepest fall reached -3157871bps in 2022.
  • Over 5 years, Operating Margin stood at 2173.64% in 2021, then crashed by -1453bps to 33752.35% in 2022, then tumbled by -75bps to 59061.3% in 2023, then dropped by -6bps to 62857.8% in 2024, then fell by -3bps to 64859.4% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 64859.4%, 55349.27%, and 62857.8% for Q4 2025, Q1 2025, and Q4 2024 respectively.